H2>Biotechnology industry is evolving to take advantage of new technologies and markets
Utilizing their knowledge of age-old Chinese herbal remedies, Hong Kong medicine manufacturers, universities, and biotechnology institutions are initiating research and development techniques that incorporate Eastern wisdom with state-of-the-art Western technology to produce medicines that comply with international standards.
The Hong Kong Institute of Biotechnology has become one of the best-equipped manufacturing technology centers for vaccines and biopharmaceuticals in Asia. The institute is targeting neurological diseases, including Alzheimer's, Parkinson's, amyo-trophic lateral sclerosis, and diabetic neuropathy.
To meet demand for future biotechnology tenant space, Hong Kong's government-owned Science Park in Tai Po is adding another 10,000 square meters (107,639 square feet) of purpose-built laboratories to its existing biotechnology facilities. Hong Kong's biotechnology industry is rapidly evolving to take advantage of new technologies and markets. Major areas of study include paharmaceuticals (drug discovery, development and delivery), biotechnology (food, animal and diagnostics), and Traditional Chinese Medicine.
Hong Kong's proximity to the Chinese mainland, one of the fastest-growing pharmceutical markets in the world, makes it an ideal operations base for international biotechnology companies seeking to exploit business potential on the mainland and the rest of Asia.